| Joshua Sypal, MD | |
|
336 S 9th St, David City, NE 68632-2116 | |
| (402) 367-3193 | |
| (402) 367-3261 |
| Full Name | Joshua Sypal |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 336 S 9th St, David City, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003227919 | NPI | - | NPPES |
| 47055317300 | Medicaid | NE | |
| 47055317313 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 7141 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Butler County Health Care Center | David city, NE | Hospital |
| The Nebraska Medical Center | Omaha, NE | Hospital |
| David Place | David city, NE | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Butler County Clinic, P.c. | 2668456245 | 4 |
News Archive
Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.
An innovative multiple sclerosis Research Fellowship designed to fast-track scientific knowledge into clinical practice has been awarded to two researchers at the University of Tasmania's Menzies Institute for Medical Research.
Betalin Therapeutics, a biotech company specializing in tissue engineering for curing diabetes, introduces the Engineered Micro Pancreas (EMP), a novel technology that provides significant levels of glucose-regulated insulin secretion over extended periods of time.
Most women who think they have a vaginal yeast infection are wrong and may be doing more harm than good in treating their problem, says a Saint Louis University researcher who presented her findings recently.
International study that included St. Jude Children's Research Hospital reports some young acute lymphoblastic leukemia patients who fail induction therapy can achieve high cure rates without bone marrow transplantation.
› Verified 7 days ago
| Entity Name | Butler County Clinic, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457311482 PECOS PAC ID: 2668456245 Enrollment ID: O20040614000760 |
News Archive
Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.
An innovative multiple sclerosis Research Fellowship designed to fast-track scientific knowledge into clinical practice has been awarded to two researchers at the University of Tasmania's Menzies Institute for Medical Research.
Betalin Therapeutics, a biotech company specializing in tissue engineering for curing diabetes, introduces the Engineered Micro Pancreas (EMP), a novel technology that provides significant levels of glucose-regulated insulin secretion over extended periods of time.
Most women who think they have a vaginal yeast infection are wrong and may be doing more harm than good in treating their problem, says a Saint Louis University researcher who presented her findings recently.
International study that included St. Jude Children's Research Hospital reports some young acute lymphoblastic leukemia patients who fail induction therapy can achieve high cure rates without bone marrow transplantation.
› Verified 7 days ago
| Entity Name | Butler County Health Care Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790780237 PECOS PAC ID: 9739281106 Enrollment ID: O20200523000123 |
News Archive
Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.
An innovative multiple sclerosis Research Fellowship designed to fast-track scientific knowledge into clinical practice has been awarded to two researchers at the University of Tasmania's Menzies Institute for Medical Research.
Betalin Therapeutics, a biotech company specializing in tissue engineering for curing diabetes, introduces the Engineered Micro Pancreas (EMP), a novel technology that provides significant levels of glucose-regulated insulin secretion over extended periods of time.
Most women who think they have a vaginal yeast infection are wrong and may be doing more harm than good in treating their problem, says a Saint Louis University researcher who presented her findings recently.
International study that included St. Jude Children's Research Hospital reports some young acute lymphoblastic leukemia patients who fail induction therapy can achieve high cure rates without bone marrow transplantation.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Sypal, MD 336 S 9th St, David City, NE 68632-2116 Ph: (402) 367-3193 | Joshua Sypal, MD 336 S 9th St, David City, NE 68632-2116 Ph: (402) 367-3193 |
News Archive
Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists, according to a University at Buffalo-led study.
An innovative multiple sclerosis Research Fellowship designed to fast-track scientific knowledge into clinical practice has been awarded to two researchers at the University of Tasmania's Menzies Institute for Medical Research.
Betalin Therapeutics, a biotech company specializing in tissue engineering for curing diabetes, introduces the Engineered Micro Pancreas (EMP), a novel technology that provides significant levels of glucose-regulated insulin secretion over extended periods of time.
Most women who think they have a vaginal yeast infection are wrong and may be doing more harm than good in treating their problem, says a Saint Louis University researcher who presented her findings recently.
International study that included St. Jude Children's Research Hospital reports some young acute lymphoblastic leukemia patients who fail induction therapy can achieve high cure rates without bone marrow transplantation.
› Verified 7 days ago
Mark Vaughn Carlson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 336 S 9th St, David City, NE 68632 Phone: 402-367-3193 Fax: 402-367-3261 | |
Victor James Thoendel, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 336 S 9th St, David City, NE 68632 Phone: 402-367-3193 Fax: 402-367-3261 | |
Gerald Walter Luckey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 336 S 9th St, David City, NE 68632 Phone: 402-367-3193 Fax: 402-367-3261 | |
Robert R Rauner, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 336 S 9th St, David City, NE 68632 Phone: 402-367-3193 Fax: 402-367-3261 | |
Dr. Robert Austin Daro, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 336 S 9th St, David City, NE 68632 Phone: 402-367-3193 Fax: 402-367-3261 | |
Jo Anna Witter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 358 S 10, David City, NE 68632 Phone: 402-367-3322 Fax: 402-367-3311 |